摘要
兰地洛尔是一个新型的超短效肾上腺素β受体阻滞药,具有选择性高、起效快、停药后失效快、对心脏血流动力学影响小等优点。兰地洛尔可减少围手术期窦性心动过速和室上性心动过速发生率,减少术后心房颤动发生率,有助于术后心房颤动患者复律,减轻经皮冠状动脉介入治疗时节律和血流动力学异常。
Landiolol is a newer ultra short-acting adrenergicβblocker,which has the advantages of highly selectivity,fast efficacy,fast offset after stopping drug and less cardiac haemodynamics effects.Landilol may decrease the occurrence of perioperative sinus tachycardia and super ventricular tachycardia,decrease the occurrence of postoperative atrial fibrillation,help to convert atrial fibrillation to sinus rhythm,attenuate the rhythm and haemodynamics abnormality during percutaneous coronary intervention.
作者
黄震华
HUANG Zhen-hua(Cardiovascular Research Room,the Ninth People's Hospital,Shanghai Jiaotong University School of Medicine,SHANGHAI 200011,China)
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2019年第4期193-197,共5页
Chinese Journal of New Drugs and Clinical Remedies
关键词
兰地洛尔
受体
肾上腺素β
抗心律失常药
心动过速
室上性
心房颤动
landiolol
receptors,adrenergic,beta
anti-arrhythmia agents
tachycardia,superventricular
atrial fibrillation